Shifting the Treatment Paradigm for Pancreaticoportal Fistula Causing Hepatic Necrosis

Dig Dis Sci. 2020 Jul;65(7):1955-1959. doi: 10.1007/s10620-020-06045-4.

Authors

Lauren M Perry¹, Thomas Loehfelm², Rex Pillai³, Dana Y Pan⁴, Sooraj Tejaswi⁴, Sepideh Gholami⁵

Affiliations

¹ Division of Surgical Oncology, Department of Surgery, University of California, 2279 45th Street, Davis, Sacramento, CA, 95817, USA.
² Division of Abdominal Imaging, Department of Radiology, University of California, Davis, USA.
³ Division of Interventional Radiology, Department of Radiology, University of California, Davis, USA.
⁴ Division of Gastroenterology, Department of Internal Medicine, University of California, Davis, USA.
⁵ Division of Surgical Oncology, Department of Surgery, University of California, 2279 45th Street, Davis, Sacramento, CA, 95817, USA. sgholami@ucdavis.edu.

PMID: 31919639
DOI: 10.1007/s10620-020-06045-4

No abstract available

Publication types

Case Reports

MeSH terms

Anti-Bacterial Agents / therapeutic use*
Cholangiopancreatography, Endoscopic Retrograde*
Cholangiopancreatography, Magnetic Resonance
Common Bile Duct / diagnostic imaging
Drainage*
Female
Humans
Imaging, Three-Dimensional
Jaundice, Obstructive / etiology
Jaundice, Obstructive / therapy*
Middle Aged
Pancreatic Fistula / diagnostic imaging
Pancreatic Fistula / etiology
Pancreatic Fistula / therapy*
Pancreatic Pseudocyst / diagnostic imaging
Pancreatic Pseudocyst / etiology
Pancreatic Pseudocyst / therapy*
Pancreatitis
Portal Vein / diagnostic imaging*
Stents*
Tomography, X-Ray Computed
Ultrasonography, Doppler, Color

Substances

Anti-Bacterial Agents